(NASDAQ: FEMY) Femasys's forecast annual revenue growth rate of 211.85% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.5%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.76%.
Femasys's revenue in 2024 is $1,049,126.On average, 2 Wall Street analysts forecast FEMY's revenue for 2024 to be $51,107,651, with the lowest FEMY revenue forecast at $42,219,364, and the highest FEMY revenue forecast at $59,995,939. On average, 1 Wall Street analysts forecast FEMY's revenue for 2025 to be $359,975,632, with the lowest FEMY revenue forecast at $359,975,632, and the highest FEMY revenue forecast at $359,975,632.
In 2026, FEMY is forecast to generate $715,507,120 in revenue, with the lowest revenue forecast at $715,507,120 and the highest revenue forecast at $715,507,120.